An Act to Require Notice to the Attorney General Prior to the Merger of Certain Health Care Entities as Recommended by the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State
LD2202 creates a new premerger notification requirement for certain health care transactions in Maine. It requires health care entities that meet specified jurisdictional triggers to concurrently file a complete electronic copy of their Hart-Scott-Rodino antitrust filing, along with additional documentary material, with the Maine Attorney General when they are involved in a merger or similar transaction. The bill defines covered entities broadly to include health care providers, health care facilities, and provider organizations, while excluding nursing facilities.
The notice requirement applies when the health care entity has its principal place of business in Maine, or when the entity or a controlled person had annual Maine revenue in the prior calendar year equal to at least 20% of the federal Hart-Scott-Rodino filing threshold for the goods or services involved in the transaction. The Attorney General is prohibited from charging a filing fee. The bill also establishes confidentiality protections for submitted materials, while allowing disclosure in certain administrative or judicial proceedings, to federal antitrust authorities, or to attorneys general in other states with substantially equivalent confidentiality protections.
The bill’s practical effect is to add a state-level review and information-gathering step to certain health care mergers and acquisitions, supplementing federal antitrust filing requirements under the Hart-Scott-Rodino Act. It would amend Maine law by adding a new section to Title 10 governing premerger notification, and it creates a civil penalty of up to $10,000 per day for noncompliance. The measure is aimed at improving oversight of health care consolidation and its effects on access to and delivery of health care services in Maine.
The overall sentiment reflected in the bill text and context is supportive of stronger oversight of health care transactions, with the legislation framed as implementing recommendations from a commission studying regulatory review of health care deals. No committee transcript or vote record is provided, so there is no recorded opposition or debate to assess directly. Based on the structure of the bill, likely points of contention would center on the burden of additional reporting, confidentiality of sensitive merger materials, and the scope of transactions and entities covered.
The bill would add a new state premerger notice regime in Title 10 for certain health care entities, requiring simultaneous filing with the Maine Attorney General when federal Hart-Scott-Rodino filings are made and the Maine nexus tests are met. It would expand the Attorney General’s access to merger-related documents, establish confidentiality rules for those materials, and authorize civil penalties for failure to comply. The affected parties are health care providers, health care facilities, and provider organizations involved in mergers, acquisitions, or similar transactions, with nursing facilities excluded.
The bill appears to have a generally favorable policy orientation toward increased oversight of health care consolidation and antitrust review. Its title and operative provisions indicate it is intended to implement recommendations from a commission focused on regulatory review of health care transactions, suggesting institutional support for the concept. Because no committee discussion or vote history is included, there is no direct evidence of recorded opposition, amendments, or partisan division in the available materials.
The main potential areas of contention are the added compliance burden on health care entities, the breadth of the entities and transactions covered, and the handling of confidential business information submitted to the Attorney General. Stakeholders opposed to the bill may argue that duplicative state filing requirements could slow transactions or increase costs, while supporters are likely to emphasize transparency and oversight of health care market consolidation. The confidentiality provisions and the $10,000-per-day civil penalty for noncompliance are also likely to be significant points of debate.